Literature DB >> 16849791

Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors.

Cornelius J Clancy1, M Hong Nguyen, Ruth Alandoerffer, Shaoji Cheng, Kenneth Iczkowski, Malcolm Richardson, John R Graybill.   

Abstract

Cryptococcus neoformans is a common cause of meningoencephalitis among AIDS patients. Several C. neoformans virulence factors have been identified, but the relative importance of particular factors is unknown. This study examined the correlation of the virulence of 18 C. neoformans var. grubii isolates from AIDS patients with the expression of several well-described virulence factors. The LD50 at 15 days after intracranial inoculation of ICR mice was <100 c.f.u. for 22 % of isolates, 100-1000 for 28 %, 1000-10,000 for 11 % and >20,000 for 39 %. Higher cryptococcal concentrations in brains were noted for isolates with lower LD50 (P = 0.002). In survival studies, no immunocompetent BALB/c mice (nu/-) infected with 3 x LD50 of three virulent isolates (LD50 = 62, 99, 1280) survived beyond 23 days, whereas 100 %, 90 % and 90 % of mice infected with 20,000 c.f.u. of three hypovirulent isolates (LD50 > 20,000) survived for 60 days (P < 0.0001). Even among BALB/c nude (nu/nu) mice, survival rates over 60 days were 100 %, 70 % and 50 %, respectively, for the hypovirulent isolates. Growth rate at 37 degrees C and capsule size within brains correlated with LD50 by univariate (P = 0.0001 and 0.028, respectively) and multivariate (P = 0.017 and 0.016, respectively) analyses. There was no correlation between LD50 and capsule size in vitro, phospholipase activity, melanin formation, proteinase activity and fluconazole MIC. In conclusion, AIDS patients are susceptible to infection by C. neoformans isolates of wide-ranging virulence, including isolates that are markedly hypovirulent. The virulence of a given isolate reflects a composite of factors rather than the contribution of a dominant factor. Growth at 37 degrees C and capsule size in vivo make particularly important contributions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849791     DOI: 10.1099/mic.0.28798-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  18 in total

1.  The Mouse Inhalation Model of Cryptococcus neoformans Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential Virulence.

Authors:  Liliane Mukaremera; Tami R McDonald; Judith N Nielsen; Christopher J Molenaar; Andrew Akampurira; Charlotte Schutz; Kabanda Taseera; Conrad Muzoora; Graeme Meintjes; David B Meya; David R Boulware; Kirsten Nielsen
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

2.  Refractory and/or Relapsing Cryptococcosis Associated with Acquired Immune Deficiency Syndrome: Clinical Features, Genotype, and Virulence Factors of Cryptococcus spp. Isolates.

Authors:  Erika Nascimento; Lucia H Vitali; Ludmilla Tonani; Marcia R Von Zeska Kress; Osvaldo M Takayanagui; Roberto Martinez
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

3.  Phenotypic differences of Cryptococcus molecular types and their implications for virulence in a Drosophila model of infection.

Authors:  George R Thompson; Nathaniel Albert; Greg Hodge; Machelle D Wilson; Jane E Sykes; Derek J Bays; Carolina Firacative; Wieland Meyer; Dimitrios P Kontoyiannis
Journal:  Infect Immun       Date:  2014-05-05       Impact factor: 3.441

4.  Role of host sphingosine kinase 1 in the lung response against Cryptococcosis.

Authors:  Travis McQuiston; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

Review 5.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

6.  Development of real-time in vivo imaging of device-related Staphylococcus epidermidis infection in mice and influence of animal immune status on susceptibility to infection.

Authors:  Cuong Vuong; Stanislava Kocianova; Jun Yu; Jagath L Kadurugamuwa; Michael Otto
Journal:  J Infect Dis       Date:  2008-07-15       Impact factor: 5.226

7.  Most environmental isolates of Cryptococcus neoformans var. grubii (serotype A) are not lethal for mice.

Authors:  Anastasia P Litvintseva; Thomas G Mitchell
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

8.  The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest.

Authors:  Karen H Bartlett; Sarah E Kidd; James W Kronstad
Journal:  Curr Infect Dis Rep       Date:  2008-03       Impact factor: 3.725

9.  Toward an integrated model of capsule regulation in Cryptococcus neoformans.

Authors:  Brian C Haynes; Michael L Skowyra; Sarah J Spencer; Stacey R Gish; Matthew Williams; Elizabeth P Held; Michael R Brent; Tamara L Doering
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

10.  Comparative Genomics of Serial Isolates of Cryptococcus neoformans Reveals Gene Associated With Carbon Utilization and Virulence.

Authors:  Kate L Ormerod; Carl A Morrow; Eve W L Chow; I Russel Lee; Samantha D M Arras; Horst Joachim Schirra; Gary M Cox; Bettina C Fries; James A Fraser
Journal:  G3 (Bethesda)       Date:  2013-04-09       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.